BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36376711)

  • 1. Prognostic impact of tumor microenvironment-related markers in patients with adenocarcinoma of the lung.
    Sugai M; Yanagawa N; Shikanai S; Osakabe M; Maemondo M; Saito H; Sugai T
    Int J Clin Oncol; 2023 Feb; 28(2):229-239. PubMed ID: 36376711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of tumor microenvironment-related markers with clinical outcomes in patients with squamous cell carcinoma of the lung.
    Sugai M; Yanagawa N; Shikanai S; Hashimoto M; Saikawa H; Osakabe M; Saito H; Maemondo M; Sugai T
    Transl Lung Cancer Res; 2022 Jun; 11(6):975-990. PubMed ID: 35832444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microenvironmental markers are correlated with lymph node metastasis in invasive submucosal colorectal cancer.
    Sugai T; Yamada N; Osakabe M; Hashimoto M; Uesugi N; Eizuka M; Tanaka Y; Sugimoto R; Yanagawa N; Matsumoto T
    Histopathology; 2021 Oct; 79(4):584-598. PubMed ID: 33884652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of combining immunohistochemical markers for cancer-associated fibroblasts in lung adenocarcinoma tissue.
    Inoue C; Tamatsuki D; Miki Y; Saito R; Okada Y; Sasano H
    Virchows Arch; 2019 Aug; 475(2):181-189. PubMed ID: 31134329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Podoplanin-positive cancer-associated fibroblasts in the tumor microenvironment induce primary resistance to EGFR-TKIs in lung adenocarcinoma with EGFR mutation.
    Yoshida T; Ishii G; Goto K; Neri S; Hashimoto H; Yoh K; Niho S; Umemura S; Matsumoto S; Ohmatsu H; Iida S; Niimi A; Nagai K; Ohe Y; Ochiai A
    Clin Cancer Res; 2015 Feb; 21(3):642-51. PubMed ID: 25388165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression Patterns of Microenvironmental Factors and Tenascin-C at the Invasive Front of Stage II and III Colorectal Cancer: Novel Tumor Prognostic Markers.
    Hashimoto M; Uesugi N; Osakabe M; Yanagawa N; Otsuka K; Kajiwara Y; Ueno H; Sasaki A; Sugai T
    Front Oncol; 2021; 11():690816. PubMed ID: 34490089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Podoplanin expression in cancer-associated fibroblasts predicts unfavourable prognosis in patients with pathological stage IA lung adenocarcinoma.
    Kubouchi Y; Yurugi Y; Wakahara M; Sakabe T; Haruki T; Nosaka K; Miwa K; Araki K; Taniguchi Y; Shiomi T; Nakamura H; Umekita Y
    Histopathology; 2018 Feb; 72(3):490-499. PubMed ID: 28881047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of cancer-associated fibroblasts and the epithelial-mesenchymal transition in cutaneous basal cell carcinoma, squamous cell carcinoma, and malignant melanoma.
    Sasaki K; Sugai T; Ishida K; Osakabe M; Amano H; Kimura H; Sakuraba M; Kashiwa K; Kobayashi S
    Hum Pathol; 2018 Sep; 79():1-8. PubMed ID: 29555579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abundant tumor promoting stromal cells in lung adenocarcinoma with hypoxic regions.
    Nakamura H; Ichikawa T; Nakasone S; Miyoshi T; Sugano M; Kojima M; Fujii S; Ochiai A; Kuwata T; Aokage K; Suzuki K; Tsuboi M; Ishii G
    Lung Cancer; 2018 Jan; 115():56-63. PubMed ID: 29290263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Podoplanin-positive cancer-associated fibroblasts could have prognostic value independent of cancer cell phenotype in stage I lung squamous cell carcinoma: usefulness of combining analysis of both cancer cell phenotype and cancer-associated fibroblast phenotype.
    Ono S; Ishii G; Nagai K; Takuwa T; Yoshida J; Nishimura M; Hishida T; Aokage K; Fujii S; Ikeda N; Ochiai A
    Chest; 2013 Apr; 143(4):963-970. PubMed ID: 23081722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Link between tumor-promoting fibrous microenvironment and an immunosuppressive microenvironment in stage I lung adenocarcinoma.
    Sakai T; Aokage K; Neri S; Nakamura H; Nomura S; Tane K; Miyoshi T; Sugano M; Kojima M; Fujii S; Kuwata T; Ochiai A; Iyoda A; Tsuboi M; Ishii G
    Lung Cancer; 2018 Dec; 126():64-71. PubMed ID: 30527194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-21 in cancer-associated fibroblasts supports lung adenocarcinoma progression.
    Kunita A; Morita S; Irisa TU; Goto A; Niki T; Takai D; Nakajima J; Fukayama M
    Sci Rep; 2018 Jun; 8(1):8838. PubMed ID: 29892003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Periostin- and podoplanin-positive cancer-associated fibroblast subtypes cooperate to shape the inflamed tumor microenvironment in aggressive pancreatic adenocarcinoma.
    Neuzillet C; Nicolle R; Raffenne J; Tijeras-Raballand A; Brunel A; Astorgues-Xerri L; Vacher S; Arbateraz F; Fanjul M; Hilmi M; Samain R; Klein C; Perraud A; Rebours V; Mathonnet M; Bièche I; Kocher H; Cros J; Bousquet C
    J Pathol; 2022 Dec; 258(4):408-425. PubMed ID: 36102377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Podoplanin expression by cancer associated fibroblasts predicts poor prognosis of lung adenocarcinoma.
    Kawase A; Ishii G; Nagai K; Ito T; Nagano T; Murata Y; Hishida T; Nishimura M; Yoshida J; Suzuki K; Ochiai A
    Int J Cancer; 2008 Sep; 123(5):1053-9. PubMed ID: 18546264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Podoplanin-positive cancer-associated fibroblast recruitment within cancer stroma is associated with a higher number of single nucleotide variants in cancer cells in lung adenocarcinoma.
    Nakasone S; Mimaki S; Ichikawa T; Aokage K; Miyoshi T; Sugano M; Kojima M; Fujii S; Kuwata T; Ochiai A; Tsuboi M; Goto K; Tsuchihara K; Ishii G
    J Cancer Res Clin Oncol; 2018 May; 144(5):893-900. PubMed ID: 29511884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Podoplanin, α-smooth muscle actin or S100A4 expressing cancer-associated fibroblasts are associated with different prognosis in colorectal cancers.
    Choi SY; Sung R; Lee SJ; Lee TG; Kim N; Yoon SM; Lee EJ; Chae HB; Youn SJ; Park SM
    J Korean Med Sci; 2013 Sep; 28(9):1293-301. PubMed ID: 24015033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel therapeutic candidate, NRK, in primary cancer-associated fibroblasts of lung adenocarcinoma microenvironment.
    Wei T; Song J; Liang K; Li L; Mo X; Huang Z; Chen G; Mao N; Yang J
    J Cancer Res Clin Oncol; 2021 Apr; 147(4):1049-1064. PubMed ID: 33387038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broadening Drug Design and Targets to Tumor Microenvironment? Cancer-Associated Fibroblast Marker Expression in Cancers and Relevance for Survival Outcomes.
    Dzobo K; Dandara C
    OMICS; 2020 Jun; 24(6):340-351. PubMed ID: 32496971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic significance of cancer-associated fibroblasts in esophageal squamous cell carcinoma.
    Ha SY; Yeo SY; Xuan YH; Kim SH
    PLoS One; 2014; 9(6):e99955. PubMed ID: 24945657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of cancer-associated stromal cells in patients with stage I lung adenocarcinoma.
    Ito M; Ishii G; Nagai K; Maeda R; Nakano Y; Ochiai A
    Chest; 2012 Jul; 142(1):151-158. PubMed ID: 22302300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.